HomeINDUSTRY EXPERT ARTICLES

INDUSTRY EXPERT ARTICLES

Focusing Solely on US Patents Can Be a Risky Move. Here’s Why | By Christopher Cauble

Christopher Cauble's view is that the U.S. healthcare market is big enough that good profits can be made without having to bother with the hassle of foreign patent protection, particularly patent protection in China. Read on to learn more.

The Perils of Over-Regulating AI in Healthcare and Life Sciences | By Adnan Masood, PhD. Chief AI Architect

As an AI researcher and practitioner deeply embedded in the healthcare and life sciences sectors, Dr. Masood sees the passage of California's SB 1047 as a complex issue with significant implications. He writes this controversial bill, now heading to Governor Newsom’s desk, represents a fundamental misunderstanding of AI as a general-purpose technology. It attempts to regulate the technology itself rather than focusing on specific, problematic applications.

Advancing Fully Implanted Hearing Systems | By Brent Lucas, CEO of Envoy Medical

Envoy Medical has taken a different approach with its fully implanted hearing devices, and it looks to turn the industry on its… ear. "Listen" to what Brent Lucas, CEO of the company has to say.

Providing Safe and Accessible Options for Women’s Reproductive Care

When it comes to reproductive care, more options, more accessibility, more affordability and a better focus on women’s choices should be everyone’s goal for the medical community by 2030.

Beyond the Device: How Remote Monitoring Devices & AI-Enabled Analytics are Shaping the Next Generation of Healthcare | By Stuart Long, CEO, InfoBionic.Ai

Along with the rising sophistication of inpatient medical devices, data acuity in remote patient monitoring devices is also on the rise. Virtual telemetry, for example, enables the continuous collection of health data like heart rate and blood pressure from nearly anywhere a patient may be located.

Engineering Better Healthcare: The Vital Role of Usability Testing and HFE/UE in Medical Device Development | By Oliver Eikenberg

Both HFE and UE are based on the international usability standards IEC 62366-1 and IEC 62366-2 with consideration of risk management (ISO 14971). By planning and integrating usability testing for human interaction with medical device technology throughout the device lifecycle and risk management processes, HFE/UE ensures that medical devices meet the complex needs of healthcare professionals and patients, and that user-related and use-related risks are eliminated or mitigated.

Scaling with Demand: Requirements for Success in Medical Device Manufacturing | By Laura Beckwith, Director of Product Management, Configit

Our expert writes: Historically, medical device companies have provided value by producing equipment for diagnosing and treating patients worldwide. However, contemporary challenges such as heightened pricing pressures, regulatory compliance, supply chain volatility and operational inefficiencies have significantly changed the landscape for these companies.

Optimizing Biopharma Workflows: Integrating AI to Enhance Research and Discovery | By Christian Olsen, Associate VP & Industry Principal for Biologics at Dotmatics

The integration of AI in biopharma workflows is not just a technological advancement, but a paradigm shift that promises to completely revolutionize how we research, understand, and treat diseases. Read what this expert has to say.

Plaque Quantification In Coronary Arteries Is a ‘Game-changer’ | By Campbell Rogers, M.D., F.A.C.C., Executive Vice President & Chief Medical Officer, HeartFlow

Artificial intelligence provides a simpler and faster alternative and could be a potential game-changer for their heart patients. For example, HeartFlow’s AI-enabled Plaque Analysis tool leverages an automated, deep learning-based, non-invasive method for identifying, characterizing, and segmenting plaque throughout the coronary arteries. By offering a more comprehensive view, plaque analysis tools can improve diagnostic accuracy, enhance treatment planning, and help stratify risk.